Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on […]
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on […]
